VKTX241122P57000
- 8.36
- +0.27+3.34%
Viking Therapeutics Newsroom
We're Interested To See How Viking Therapeutics (NASDAQ:VKTX) Uses Its Cash Hoard To Grow
3 Things You Need to Know If You Buy Viking Therapeutics Today
Is It Too Late to Buy Viking Therapeutics Stock?
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
Express News | Shares of Pharmaceutical and Healthcare Stocks Are Trading Lower. The Sector Has Been Under Pressure After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS
Eli Lilly, Novo Nordisk Shares Slide as Trump Picks RFK Jr. for HHS Post
Trending Industry Today: Viking Therapeutics Leads Losses In Weight Loss Drugs Stocks
Market Whales and Their Recent Bets on VKTX Options
Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Raises Target Price to $164
Oppenheimer Sticks to Their Buy Rating for Viking Therapeutics (VKTX)
Eli Lilly and Co. is startled, novo-nordisk a/s saves the day! The market prospects for weight loss drugs still tempt many players.
The weight loss drug market still has a broad prospect, with most institutions predicting that the market size will reach the trillion-dollar level by the end of this decade.
10 Health Care Stocks With Whale Alerts In Today's Session
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
Viking Therapeutics to Present Data From Phase 2b VOYAGE Study of VK2809 in Patients With Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024
Is Viking Therapeutics a Buy on the Dip?
4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move
Peace Medical Acquired by Experienced Healthcare Professional, Ensuring Continuity and Growth
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
Viking Therapeutics (VKTX) Stock Surges on Promising Treatment Pipeline
Viking Therapeutics Offers An Obesity Drug for Healthy Adults